RLRussell V. Luepker

Russell V. Luepker

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Russell V. Luepker has a total of 45 co-authors. Here are the top co-authors by number of shared publications:

  • Sue Duval

    Cardiovascular Division, University of Minnesota, Minneapolis, MN, USA

    4 shared publications
  • David R. Jacobs

    From the University of Minnesota, School of Public Health, Division of Epidemiology and Community Health, Minneapolis, MN

    3 shared publications
  • Alan K. Berger

    University of Minnesota, School of Public Health, Division of Epidemiology and Community Health

    2 shared publications
  • Henry Blackburn

    From the University of Minnesota, School of Public Health, Division of Epidemiology and Community Health, Minneapolis, MN

    2 shared publications
  • Lyn M. Steffen

    Division of Epidemiology and Community Health, School of Public Health, University of Minnesota, Minneapolis, Minnesota

    2 shared publications
  • Xia Zhou

    Division of Epidemiology and Community Health, School of Public Health, University of Minnesota, Minneapolis, MN (R.V.L., L.M.S., X.Z., A.T.H.).

    2 shared publications

Latest Publications

  • Open Access

    Smoking and Passive Smoking

    by Russell V. Luepker


  • Open Access

    Population Trends in Aspirin Use for Cardiovascular Disease Prevention 1980–2009: The Minnesota Heart Survey

    by Russell V. Luepker, Lyn M. Steffen, Sue Duval, Nicole D. Zantek, Xia Zhou, Alan T. Hirsch

    Background: Daily low‐dose aspirin is recommended for primary prevention of myocardial infarction and stroke in higher‐risk patients. Population trends in aspirin use for cardiovascular disease (CVD) prevention in an urban population (Minneapolis/St. Paul, 2010 population 2.85 million) from 1980 to 2009 were evaluated. Methods and Results: Surveys of randomly selected adults aged 25 to 74 years were collected at 5‐year intervals. Self‐reports of regular aspirin use for CVD prevention and history of CVD were obtained. Six cross‐sectional surveys included 12 281 men and 14 258 women. Age‐adjusted aspirin use for primary prevention increased during this period from 1% to 21% among men and 1% to 12% among women. Aspirin use was highest in those aged 65 to 74 years. For secondary prevention, age‐adjusted aspirin use increased from 19% to 74% among men and 11% to 64% among women. While data are based on self‐report, a substudy using a biochemical indicator of aspirin use (serum thromboxane B 2 ) supports the validity of self‐report. Conclusions: Aspirin for CVD prevention is commonly used by a large and growing portion of the general population. It is not known if this is based on professional advice or self‐prescribed use. It is also likely that many who would benefit do not use aspirin and others use aspirin inappropriately.


  • Open Access

    Vital exhaustion: ready for prime time?

    by Russell V. Luepker, S. Charles Schulz

    This editorial refers to ‘Ranking of psychosocial and traditional risk factors by importance for coronary heart disease: the Copenhagen City Heart Study’†, by P. Schnohr et al. on page 1385.


  • Open Access

    The FReedom from Ischemic Events - New Dimensions for Survival (FRIENDS) registry: design of a prospective cohort study of patients with advanced peripheral artery disease

    by Hong H Keo, Sue Duval, Iris Baumgartner, Niki C Oldenburg, Michael R Jaff, JoAnne Goldman, James M Peacock, Alexander S Tretinyak, Timothy D Henry, Russell V Luepker, et al.

    Advanced lower extremity peripheral artery disease (PAD), whether presenting as acute limb ischemia (ALI) or chronic critical limb ischemia (CLI), is associated with high rates of cardiovascular ischemic events, amputation, and death. Past research has focused on strategies of revascularization, but few data are available that prospectively evaluate the impact of key process of care factors (spanning pre-admission, acute hospitalization, and post-discharge) that might contribute to improving short and long-term health outcomes. The FRIENDS registry is designed to prospectively evaluate a range of patient and health system care delivery factors that might serve as future targets for efforts to improve limb and systemic outcomes for patients with ALI or CLI. This hypothesis-driven registry was designed to evaluate the contributions of: (i) pre-hospital limb ischemia symptom duration, (ii) use of leg revascularization strategies, and (iii) use of risk-reduction pharmacotherapies, as pre-specified factors that may affect amputation-free survival. Sequential patients would be included at an index “vascular specialist-defined” ALI or CLI episode, and patients excluded only for non-vascular etiologies of limb threat. Data including baseline demographics, functional status, co-morbidities, pre-hospital time segments, and use of medical therapies; hospital-based use of revascularization strategies, time segments, and pharmacotherapies; and rates of systemic ischemic events (e.g., myocardial infarction, stroke, hospitalization, and death) and limb ischemic events (e.g., hospitalization for revascularization or amputation) will be recorded during a minimum of one year follow-up. The FRIENDS registry is designed to evaluate the potential impact of key factors that may contribute to adverse outcomes for patients with ALI or CLI. Definition of new “health system-based” therapeutic targets could then become the focus of future interventional clinical trials for individuals with advanced PAD.


  • Cigarette Smoking and Cardiovascular Disease: Lessons from Framingham

    by Kristian B. Filion, Russell V. Luepker

    Cigarette smoking, causing acute and chronic diseases, is a serious threat to the health of the public. The association of smoking with lung cancer was recognized first, but the relationship of smoking to cardiovascular disease was debated into the 1960s and early data from the Framingham cohort found no association. However, in 1962, an analysis combining the data from the Framingham men with the Albany, New York, male cohort found cigarette smoking predicted myocardial infarction, coronary heart disease mortality, and all-cause mortality. The same year, Framingham investigators wrote that smoking was a cardiovascular risk factor independent of other characteristics, such as blood pressure, cholesterol, and smoking cessation, and should be included in any prevention program. The first surgeon general's report was released in 1964 and Framingham investigators were participants in the report's development and provided important data on the association of cigarettes with cardiovascular disease. Subsequent analyses confirmed the early findings on the benefits of quitting for primary prevention of cardiovascular disease and secondary prevention after myocardial infarction. The Framingham investigators and cohort data played a crucial role in the current understanding of the dangers of cigarettes and the subsequent decline of smoking in industrialized countries.


  • Using the Web to Assist Communities in Public Health Campaign Planning: A Case Study of the REACT Project

    by John R. Finnegan, Deborah Alexander, Jason Rightmyer, Barbara Estabrook, Bernadette Gloeb, Melinda Voss, Laura Leviton, Russell V. Luepker

  • Trends in Blood Pressure and Hypertension Detection, Treatment, and Control 1980 to 2009

    by Russell V. Luepker, Lyn M. Steffen, David R. Jacobs, Xia Zhou, Henry Blackburn

    Background—: Hypertension is common and treatable, but detection and control remain a major health challenge. This study sought to determine population trends in blood pressure and in the control of hypertension in the Minneapolis/St. Paul area (2010 population, 2.85 million) from 1980 to 2009. Methods and Results—: Surveys of risk factors were performed every 5 years among randomly selected adults aged 25 to 74 years. Data on hypertension knowledge and use of medications were collected by interview. Blood pressure was measured by standardized methods, with hypertension defined as blood pressure ≥140 mm Hg systolic and/or 90 mm Hg diastolic or controlled at P P P P 50% among all adults aged 55 to 74 years. Sixty-six percent of men and 72% of women with hypertension had their hypertension treated or controlled by 2007 to 2009. A majority of the decline in mean population blood pressure was the result of control with aggressive use of antihypertensive drugs. Stroke mortality in this population fell in parallel. Conclusions—: The rate of hypertension detection and control in this community is among the highest observed in a US population and already exceeds Healthy People 2020 goals.


  • The Effect of Changing Diagnostic Algorithms on Acute Myocardial Infarction Rates

    by Russell V. Luepker, Sue Duval, David R. Jacobs, Lindsay G. Smith, Alan K. Berger